Structural unit: Institute of Medicine.
The Laboratory specializes in applying molecular genetic methods to study individual cells and bioinformatics and systems analysis approaches to understand the mechanisms of biological processes and the functioning of living organisms under both normal and pathological conditions.
Resources
Our laboratory facilities enable the use of the following research methods:
- Single-cell DNA and RNA sequencing
- Spatial transcriptomics
- Whole-genome, whole-exome, whole-transcriptome, bisulfite and targeted sequencing
- Bioinformatic analysis
Equipment Fleet
- Chromium X Platform (10x Genomics, USA)
- Genolab M Sequencing Platform (GeneMind Biosciences, China)
- KF-PRO-005 Digital Pathology Scanner (KF-BIO, China)
- Qsep400 Bio-Fragment Analyzer (BiOptic, China)
- Fluo-100 Fluorometer (Allsheng, China)
- DSC-400 Single Cell Suspension Dissociator (RWD Life Science, China)
- GeneExplorer Thermal Cycler (Bioer, China)
- Q2000 Real Time PCR (LongGene, China)
The team includes specialists in digital technologies, molecular biology and clinical medicine who have experience in big data analysis, molecular genetic and cellular research, and clinical patient management.
Capabilities
- Detection of genetic variants (SNVs, indels, CNVs) and epigenetic modifications
- Assessment of gene expression and non-coding RNAs
- Detection and construction of gene regulatory networks
- Identification of cell types and populations
- Determination of intercellular (ligand-receptor) interactions
- Analysis of cell differentiation (developmental) trajectories and phylogeny
- Metagenome analysis
Partners
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- N.N. Blokhin National Medical Research Center of Oncology
- Ivannikov Institute for System Programming of the Russian Academy of Sciences
- Development of a molecular atlas of malignant pediatric lymphoproliferative disorders
- Creation of a molecular atlas of soft tissue sarcomas
It enables:
- deciphering cellular heterogeneity,
- understanding the organization of tissues and organs,
- identifying the mechanisms of biological processes and cell origins,
- identifying clinically significant cell populations, predictive and prognostic markers, and therapeutic targets.
This methodology is key to understanding the functioning of living organisms under normal and pathological conditions and developing fundamentally new approaches to personalized disease therapy.